Analyst Ratings for Myriad Genetics (MYGN)

MYGN Rating Summary

MYGN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MYGN
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $32.89 (+52.4%) * Over Last 12-Mos
Rating Score: 2.4 / 10   Percentile Rank: 20%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
8/10/2016 Gabelli Downgrade Hold
(Buy)
N/A
(N/A)
29.46 21.58 -26.75% Details
8/10/2016 Barclays Downgrade Equalweight
(Overweight)
24.00
(50.00)
29.46 21.58 -26.75% Details
Like MYGN Ratings? Also take a look at TSRO, NVTA, ABBV

MYGN Ratings News